Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital’s fracture liaison service between January 2010 and December 2011
Authors:
- 1 July 2014
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 25 (10) , 2409-2416
Abstract
The main goal was to assess the performance of the fracture liaison service (FLS) at Amiens University Hospital for 2 years. Osteoporosis medication was prescribed in 182 patients and 67.4 % were still taking treatment 18 months later. Secondary prevention of osteoporotic fractures has improved since the creation of the FLS. The main goal of the present study was to assess the performance and results of the FLS at Amiens University Hospital, France. This was an observational, single-center, ambispective study. All patients admitted to Amiens University Hospital between January 2010 and December 2011 for a low-trauma fracture (vertebral and non-vertebral fractures) were identified by a FLS nurse. Patients willing to enter the study were assessed for their osteoporosis risk factors, daily calcium intake, bone mineral density (BMD) by DXA, and clinical chemistry parameters. When indicated, the patients received a prescription for osteoporosis medication. The participation rate, type of osteoporosis medications, initiation rate, and osteoporosis treatment persistence 12 and 18 months later were assessed. Of the 1,439 patients contacted, 872 were eligible for inclusion. A total of 335 patients (participation rate 38.4 %) were included in the study (mean age 63.3 years; 71.9 % female). All patients underwent BMD measurement, and more than 90 % of them were assessed for osteoporosis risk factors and daily calcium intake. Osteoporosis medication was prescribed in 182 (75.5 %) of the patients in whom it was indicated (n = 241). The main class of osteoporosis medications prescribed was bisphosphonates (83.5 %), and 74.1 and 67.4 % of treated patients were still taking treatment 12 and 18 months later, respectively. The main cause of treatment discontinuation was non-renewal of the prescription by the patient’s general practitioner. Secondary prevention of osteoporotic fractures in Amiens University Hospital has improved since the creation of the FLS, with encouragingly high treatment initiation and persistence rates.Keywords
This publication has 31 references indexed in Scilit:
- Denosumab in osteoporosisExpert Opinion on Drug Safety, 2013
- Optimizing fracture prevention: the fracture liaison service, an observational studyOsteoporosis International, 2013
- Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture TrialOsteoporosis International, 2013
- Secondary prevention of osteoporotic fractures—an “OPTIMAL” model of care from SingaporeOsteoporosis International, 2013
- Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and menJournal of Bone and Mineral Research, 2013
- Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycleOsteoporosis International, 2013
- Management of osteoporosis in fracture liaison service associated with long-term adherence to treatmentOsteoporosis International, 2011
- Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonatesOsteoporosis International, 2010
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- The Inpatient Consultation Approach to Osteoporosis Treatment in Patients with a FractureIs Automatic Consultation Needed?Journal of Bone and Joint Surgery, 2006